Financhill
Back

Vanda Pharmaceuticals 10K Form

Sell
37

VNDA
Vanda Pharmaceuticals

Last Price:
4.89
Seasonality Move:
7.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive VNDA News And Ratings

See the #1 stock for the next 7 days that we like better than VNDA

VNDA Financial Statistics

Sales & Book Value

Annual Sales: $192.64M
Cash Flow: $-7.04M
Price / Cash Flow: 0
Annual Sales: $9.31
Price / Book: 0.51

Profitability

EPS (TTM): -0.18760
Net Income (TTM): $-10.93M
Gross Margin: $177.84M
Return on Equity: -2.01%
Return on Assets: -1.69%

Vanda Pharmaceuticals Earnings Forecast

Key Vanda Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 18 years for VNDA is 92.32%.
  • The Selling, General & Administrative Expenses for VNDA have been equal to 58.60% of Gross Profit Margin.
  • The Research & Development expenses have been 39.88% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of VNDA is 1.30% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 11 years.

Vanda Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VNDA
CUSIP: 921659
Website: vandapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.68
Quick Ratio: 4.58

Price-to-Earnings

Trailing P/E Ratio: 119.75
Forward P/E Ratio: 0

VNDA Technical Analysis vs Fundamental Analysis

Sell
37
Vanda Pharmaceuticals (VNDA) is a Sell

Is Vanda Pharmaceuticals a Buy or a Sell?